American Kidney Fund Hosts ‘Dialysis at Home’ Summit to Share Knowledge and Resources about Home Dialysis with the Kidney Community
03 oct. 2024 09h12 HE
|
American Kidney Fund
ROCKVILLE, Md., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) is hosting the third annual Dialysis at Home summit, a free, online event in which participants will hear from...
Corporate and Individual Donations Provide Much-Needed Support to Kidney Patients Impacted by Hurricane Helene Through the American Kidney Fund’s Disaster Relief Program
02 oct. 2024 09h48 HE
|
American Kidney Fund
ROCKVILLE, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- In the wake of the devastation of Hurricane Helene across the Southeast, the American Kidney Fund’s (AKF) Disaster Relief Program is continuing to...
Comprehensive Analysis of Genitourinary Collaboration and Licensing Deals (2016-2024) Unveiled
25 sept. 2024 09h20 HE
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Genitourinary Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The genitourinary therapeutic...
Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024
24 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
American Kidney Fund’s Rare Kidney Disease Advocacy Day on Capitol Hill Seeks to Gather Support for Legislation that will Increase Awareness and Treatment of Rare Kidney Diseases
18 sept. 2024 09h59 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Members of AKF’s Rare Kidney Disease Action Network (RKDAN) and health care professionals will visit Capitol Hill in Washington, D.C. today to meet...
American Kidney Fund Hosts Annual National Summit on Unknown Causes of Kidney Disease
16 sept. 2024 09h49 HE
|
American Kidney Fund
ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- As part of its ongoing groundbreaking work to advance understanding and patient care of undiagnosed or misdiagnosed causes of kidney disease, the...
Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024
16 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
05 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
03 sept. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership Program at ‘Champion’ Level
27 août 2024 11h01 HE
|
American Kidney Fund
ROCKVILLE, Md., Aug. 27, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim and Eli Lilly and Company have joined the 2024 class in AKF’s Corporate...